These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 8359080)

  • 1. Bismuth subsalicylate suppression of Helicobacter pylori in nonulcer dyspepsia: a double-blind placebo-controlled trial.
    Marshall BJ; Valenzuela JE; McCallum RW; Dooley CP; Guerrant RL; Cohen H; Frierson HF; Field LG; Jerdack GR; Mitra S
    Dig Dis Sci; 1993 Sep; 38(9):1674-80. PubMed ID: 8359080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients with dyspepsia benefit from eradication of Helicobacter pylori if other organic causes for dyspepsia were carefully ruled out.
    Bojarski C; Epple HJ; Kirstein FW; Fromm M; Bisson S; Riecken EO; Schulzke JD
    Z Gastroenterol; 2000 Mar; 38(3):211-9. PubMed ID: 10768243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double blind trial of colloidal bismuth subcitrate versus placebo in Helicobacter pylori positive patients with non-ulcer dyspepsia.
    Vaira D; Holton J; Ainley C; Falzon M; Osborn J; D'Anna L; Romanos A; Chandrakumaran K; McNeil I
    Ital J Gastroenterol; 1992 Sep; 24(7):400-4. PubMed ID: 1392023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori gastritis and non-ulcer dyspepsia in childhood. Efficacy of one-week triple antimicrobial therapy in eradicating the organism.
    Cucchiara S; Salvia G; Az-Zeqeh N; D'Armiento FD; De Petra MR; Rapagiolo S; Campanozzi A; Emiliano M
    Ital J Gastroenterol; 1996; 28(8):430-5. PubMed ID: 9032584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of anti-Helicobacter pylori treatment in H. pylori-positive and cytoprotective drugs in H. pylori-negative, non-ulcer dyspepsia: results of a randomized, double-blind, controlled trial in Asian Indians.
    Dhali GK; Garg PK; Sharma MP
    J Gastroenterol Hepatol; 1999 Jun; 14(6):523-8. PubMed ID: 10385059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of omeprazole (40 mg) in the treatment of gastric Helicobacter pylori infection.
    Wagner S; Varrentrapp M; Haruma K; Lange P; Müller MJ; Schorn T; Soudah B; Bär W; Gebel M
    Z Gastroenterol; 1991 Nov; 29(11):595-8. PubMed ID: 1771934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind comparison of absorbable colloidal bismuth subcitrate and nonabsorbable bismuth subnitrate in the eradication of Helicobacter pylori and the relief of nonulcer dyspepsia.
    Whitehead MW; Phillips RH; Sieniawska CE; Delves HT; Seed PT; Thompson RP; Powell JJ
    Helicobacter; 2000 Sep; 5(3):169-75. PubMed ID: 10971683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind randomized trial of bismuth subsalicylate and clindamycin for treatment of Helicobacter pylori infection.
    Westblom TU; Madan E; Subik MA; Duriex DE; Midkiff BR
    Scand J Gastroenterol; 1992; 27(3):249-52. PubMed ID: 1502490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic alcoholic gastritis. Roles of alcohol and Helicobacter pylori.
    Uppal R; Lateef SK; Korsten MA; Paronetto F; Lieber CS
    Arch Intern Med; 1991 Apr; 151(4):760-4. PubMed ID: 2012461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori infection and non-ulcer dyspepsia: the effect of treatment with colloidal bismuth subcitrate.
    Goh KL; Parasakthi N; Peh SC; Wong NW; Lo YL; Puthucheary SD
    Scand J Gastroenterol; 1991 Nov; 26(11):1123-31. PubMed ID: 1754846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of antimicrobial activity of zinc chloride and bismuth subsalicylate against clinical isolates of Helicobacter pylori.
    Yakoob J; Abbas Z; Usman MW; Awan S; Naz S; Jafri F; Hamid S; Jafri W
    Microb Drug Resist; 2014 Aug; 20(4):305-9. PubMed ID: 23844851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healing of chronic antral gastritis: effect of sucralfate and colloidal bismuth subcitrate.
    Kumar M; Yachha SK; Aggarwal R; Shukla S; Pandey R; Prasad KN; Ayyagari A; Naik SR
    Indian J Gastroenterol; 1996 Jul; 15(3):90-3. PubMed ID: 8840633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved eradication rate of standard triple therapy by adding bismuth and probiotic supplement for Helicobacter pylori treatment in Thailand.
    Srinarong C; Siramolpiwat S; Wongcha-um A; Mahachai V; Vilaichone RK
    Asian Pac J Cancer Prev; 2014; 15(22):9909-13. PubMed ID: 25520127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of therapies in the treatment of Helicobacter pylori associated non-ulcer dyspepsia.
    Nafeeza MI; Shahimi MM; Kudva MV; Ahmad H; Isa MR; Sood IM; Mazlam MZ; Jamal F; Suboh Y
    Singapore Med J; 1992 Dec; 33(6):570-4. PubMed ID: 1488663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.
    Chey WD; Fisher L; Elta GH; Barnett JL; Nostrant T; DelValle J; Hasler WL; Scheiman JM
    Am J Gastroenterol; 1997 Sep; 92(9):1483-6. PubMed ID: 9317068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia.
    Talley NJ; Vakil N; Ballard ED; Fennerty MB
    N Engl J Med; 1999 Oct; 341(15):1106-11. PubMed ID: 10511608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of bismuth subsalicylate on the histologic gastritis seen with Campylobacter pylori: a placebo-controlled, randomized study.
    Lanza FL; Skoglund ML; Rack MF; Yardley JH
    Am J Gastroenterol; 1989 Sep; 84(9):1060-4. PubMed ID: 2773899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing the eradication of Helicobacter pylori with triple therapy.
    Graham DY; Lew GM; Malaty HM; Evans DG; Evans DJ; Klein PD; Alpert LC; Genta RM
    Gastroenterology; 1992 Feb; 102(2):493-6. PubMed ID: 1732120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastroduodenal mucosal prostaglandin generation in patients with Helicobacter pylori before and after treatment with bismuth subsalicylate.
    Avunduk C; Suliman M; Gang D; Polakowski N; Eastwood GL
    Dig Dis Sci; 1991 Apr; 36(4):431-4. PubMed ID: 2007360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long-term effect of Helicobacter pylori eradication therapy on symptoms in dyspeptic patients with fundic atrophic gastritis.
    Kamada T; Haruma K; Hata J; Kusunoki H; Sasaki A; Ito M; Tanaka S; Yoshihara M
    Aliment Pharmacol Ther; 2003 Jul; 18(2):245-52. PubMed ID: 12869086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.